Live Breaking News & Updates on Key Secondary Outcomes

Stay updated with breaking news from Key secondary outcomes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Vertex Announces Positive Results From Pivotal Trials of Vanzacaftor/Tezacaftor/Deutivacaftor, Next-

– Treatment with the once-daily vanza triple CFTR modulator regimen met all primary and key secondary endpoints in two randomized controlled trials in people with CF ages 12 years and older –– Results were more pronounced in the single-arm study in children ages 6 to 11 years, demonstrating the potential that treati. ....

Heather Nichols , Bonnie Ramsey , Carmen Bozic , Cf Foundation Therapeutics Development Network , University Of Washington School Medicine , Global Medicines Development , Vertex Pharmaceuticals Incorporated , Vertex Pharmaceuticals Incorporated Nasdaq , Drug Administration , Treatment Group , European Medicines Agency , Modulator Steering Committee , Executive Vice President , Medical Affairs , Chief Medical Officer , Professor Emerita , Washington School , Senior Consultant , Therapeutics Development Network , Key Secondary Outcomes , Active Controlled Phase , Absolute Change , Key Secondary Endpoint , Sweat Chloride , Pooled Across , Single Arm ,

Vertex Announces Positive Results From the VX-548 Phase 3 Program for the Treatment of Moderate-to-Severe Acute Pain

– Treatment with VX-548 led to statistically significant improvement in pain compared to placebo as well as a clinically meaningful reduction in pain from baseline in both the abdominoplasty and. ....

United States , City Of , United Kingdom , Jessica Oswald , Reshma Kewalramani , Exchange Commission , Vertex Pharmaceuticals Conference Call , Vertex Pharmaceuticals Incorporated Nasdaq , Companies To Work , Drug Administration , Vertex Pharmaceuticals Incorporated , Acute Pain Following Abdominoplasty , Business Wire , Numeric Pain Rating Scale , Patients Undergoing , Key Secondary Outcomes , Acute Pain Following , From Baseline , Acute Pain Following Bunionectomy , Effectiveness Study , New Drug Application , Breakthrough Therapy , Fast Track , Pharmaceuticals Conference Call , North America , Latin America ,

Vertex Pharma (VRTX) Reports Positive Results From the VX-548 Phase 3 Program

Vertex Pharma (VRTX) Reports Positive Results From the VX-548 Phase 3 Program
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , City Of , United Kingdom , Reshma Kewalramani , Jessica Oswald , Companies To Work , Drug Administration , Vertex Pharmaceuticals Incorporated Nasdaq , Vertex Pharmaceuticals Incorporated , Vertex Pharmaceuticals Conference Call , Exchange Commission , Numeric Pain Rating Scale , Patients Undergoing , Key Secondary Outcomes , Acute Pain Following , Acute Pain Following Abdominoplasty , From Baseline , Acute Pain Following Bunionectomy , Effectiveness Study , New Drug Application , Breakthrough Therapy , Fast Track , Pharmaceuticals Conference Call , North America , Latin America , Top Employers ,

Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial | Diabetes | JAMA

This clinical trial compares the efficacy of continuous glucose monitoring (CGM) vs traditional blood glucose meter monitoring on glycemic control in adults wit ....

United Kingdom , United States , International Center , Las Vegas , Royw Beck , Eli Lily , Eli Lilly , Health Research Foundation Inc , Omada Health , Boehringer Ingelheim Pharmaceuticals Inc , International Diabetes Center , Boehringer Ingelheim , Theracos Sub , Sanofi Aventis , Teijin America Inc , Nutrition Examination Survey , Dexcom Inc , National Institutes Of Health , University Of Minnesota Advanced Research Diagnostic Laboratory , Madrigal Pharmaceuticals , Novo Nordisk , Xeris Pharmaceuticals , National Health , American Diabetes Association , Bristol Myers Squibb , United Biosource Corp ,